A. Guillouzo and C. Guguen-guillouzo, Evolving concepts in liver tissue modeling and implications for in vitro toxicology, Expert Opin. Drug. Metab. Toxicol, vol.4, pp.1279-1294, 2008.

K. E. Lasser, P. D. Allen, S. J. Woolhandler, D. U. Himmelstein, S. M. Wolfe et al., Timing of new black box warnings and withdrawal for prescription medications, JAMA, vol.287, pp.2215-2220, 2002.

W. Suter, Predictive value of in vitro safety studies, Curr. Opin. Chem. Biol, vol.10, pp.362-366, 2006.

N. Quesnot, Evaluation de la génotoxicité des contaminants environnementaux, production de lignées bio-senseurs et mesure de l'activité enzymatique du cytochrome P450 2E1 dans les cellules d'hépatome HepaRG, Philosophy, University of Rennes, vol.1, 2015.

M. Vinken and J. G. Hengstler, Characterization of hepatocyte-based in vitro systems for reliable toxicity testing, Arch. Toxicol, vol.92, pp.2981-2986, 2018.

M. Audebert, A. Riu, C. Jacques, A. Hillenweck, E. L. Jamin et al., Use of the H2AX assay for assessing the genotoxicity of polycyclic aromatic hydrocarbons in human cell lines, Toxicol. Lett, vol.199, pp.182-192, 2010.

S. Wilkening, F. Stahl, and A. Bader, Comparison of primary human hepatocytes and hepatoma cell line HepG2 with regard to their biotransformation properties, Drug Metab. Dispos, vol.31, pp.1035-1042, 2003.

D. Glaise, G. P. Ilyin, P. Loyer, S. Cariou, M. Bilodeau et al., Cell cycle gene regulation in reversibly differentiated new human hepatoma cell line, Cell Growth Differ, vol.9, pp.165-176, 1998.

J. H. Kelly, Permanent Human Hepatocyte Cell Line and Its Use in a, Liver Assist Device (LAD). U.S. Patent, vol.290, issue.5, 1994.

T. Hashizume, S. Yoshitomi, S. Asahi, R. Uematsu, S. Matsumura et al., Advantages of human hepatocyte-derived transformants expressing a series of human cytochrome P450 isoforms for genotoxicity examination, Toxicol. Sci, vol.116, pp.488-497, 2010.

R. Jover, R. Bort, M. J. Gomez-lechon, and J. V. Castell, Re-expression of C/EBP alpha induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells, FEBS Lett, vol.431, pp.227-230, 1998.

P. Gripon, S. Rumin, S. Urban, J. Le-seyec, D. Glaise et al., Infection of a human hepatoma cell line by hepatitis B virus, Proc. Natl. Acad. Sci, vol.99, pp.15655-15660, 2002.

V. Cerec, D. Glaise, D. Garnier, S. Morosan, B. Turlin et al., Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor, Hepatology, vol.45, pp.957-967, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00690471

H. Dubois-pot-schneider, K. Fekir, C. Coulouarn, D. Glaise, C. Aninat et al., Inflammatory cytokines promote the retrodifferentiation of tumor-derived hepatocyte-like cells to progenitor cells, Hepatology, vol.60, pp.2077-2090, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01134747

C. Aninat, A. Piton, D. Glaise, T. Le-charpentier, S. Langouet et al., Expression of cytochrome P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells, Drug Metab. Dispos, vol.34, pp.2245-2261, 2006.

L. Vee, M. Noel, G. Jouan, E. Stieger, B. Fardel et al., Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells, Toxicol. In Vitro, vol.27, 1979.
URL : https://hal.archives-ouvertes.fr/hal-00866007

N. Quesnot, S. Bucher, C. Gade, M. Vlach, E. Vène et al., Production of chlorzoxazone glucuronides via cytochrome P4502E1 dependent and independent pathways in human hepatocytes, Arch. Toxicol, vol.92, pp.3077-3091, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01863847

J. Dumont, R. Jossé, C. Lambert, S. Anthérieu, V. Laurent et al., Preferential induction of the AhR gene battery in HepaRG cells after a single or repeated exposure to heterocyclic aromatic amines, Toxicol. Appl. Pharmacol, vol.249, pp.91-100, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00742145

C. Legendre, T. Hori, P. Loyer, C. Aninat, S. Ishida et al., Drug-metabolising enzymes are down-regulated by hypoxia in differentiated human hepatoma HepaRG cells: HIF1-alpha involvement in CYP3A4 repression, Eur. J. Cancer, vol.12, pp.2882-2892, 2009.

R. Jossé, C. Aninat, D. Glaise, J. Dumont, V. Fessard et al., Long-term functional stability of HepaRG hepatocytes and use for chronic toxicity and genotoxicity studies, Drug Metab. Dispos, vol.36, pp.1111-1118, 2008.

K. Pernelle, R. Le-guevel, D. Glaise, C. G. Stasio, T. Le-charpentier et al., Automated detection of hepatotoxic compounds in human hepatocytes using HepaRG cells and image-based analysis of mitochondrial dysfunction using JC-1 dye, Toxicol. Appl. Pharmacol, vol.254, pp.256-266, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00740177

M. J. Jetten, J. C. Kleinjans, S. M. Claessen, C. Chesné, and J. H. Van-delft, Baseline and genotoxic compound induced gene expression profiles in HepG2 and HepaRG compared to primary human hepatocytes, Toxicol. In Vitro, vol.27, pp.2031-2040, 2013.

N. Quesnot, K. Rondel, S. Martinais, M. Audebert, D. Glaise et al., Evaluation of genotoxicity using automated detection of gammaH2AX in metabolically competent HepaRG cells, Mutagenesis, vol.31, pp.43-50, 2016.

Z. Abdel-razzak, P. Loyer, A. Fautrel, J. Gautier, L. Corcos et al., Cytokines down-regulate major cytochrome P450 in primary culture of human hepatocytes, Mol. Pharmacol, vol.44, pp.707-715, 1993.

S. Langouet, L. Corcos, Z. Abdel-razzak, P. Loyer, B. Ketterer et al., Up regulation of glutathione S-transferases alpha by interleukin 4 in human hepatocytes in primary culture, Biochem. Biophys. Res. Commun, vol.216, pp.793-800, 1995.

S. Tsuji, F. Kawamura, A. Hayashi, T. Ohbayashi, Y. Kazuki et al., Dual-color fluorescence imaging to monitor CYP3A4 and CYP3A7 expression in human hepatic carcinoma HepG2 and HepaRG cells, PLoS ONE, vol.9, 2014.

T. Ueyama, S. Tsuji, and M. Tada, Fluorometric evaluation of CYP3A4 expression using improved transgenic HepaRG cells carrying a dual-colour reporter for CYP3A4 and CYP3A7, Sci. Rep, 2017.

R. C. Casabar, P. C. Das, G. K. Dekrey, C. S. Gardiner, Y. Cao et al., Endosulfan induces CYP2B6 and CYP3A4 by activating the pregnane X receptor, Toxicol. Appl. Pharmacol, vol.245, pp.335-343, 2010.

T. Blagus, V. Zager, M. Cemazar, G. Sersa, U. Kamensek et al., A cell-based biosensor system HepG2CDKN1A-DsRed for rapid and simple detection of genotoxic agents, Biosens. Bioelectron, vol.64, pp.102-111, 2014.

A. Corlu and P. Loyer, Culture conditions promoting hepatocyte proliferation and cell cycle synchronization, Protocols in In Vitro Hepatocyte Research
URL : https://hal.archives-ouvertes.fr/hal-01187298

A. Piton, C. Rauch, S. Langouet, A. Guillouzo, and F. Morel, Involvement of pregnane X receptor in the regulation of CYP2B6 gene expression by oltipraz in human hepatocytes, Toxicol. In Vitro, vol.24, pp.452-459, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00666115

I. Ayed-boussema, J. Pascussi, P. Maurel, H. Bacha, and W. Hassen, Zearalenone activates pregnane X receptor, constitutive androstane receptor and aryl hydrocarbon receptor and corresponding phase I target genes mRNA in primary cultures of human hepatocytes, Environ. Toxicol. Pharmacol, vol.31, pp.79-87, 2011.

D. Gilot, P. Loyer, A. Corlu, D. Glaise, D. Lagadic-gossmann et al., Liver protection from apoptosis requires both blockage of initiator caspase activities and inhibition of ASK1/JNK pathway via glutathione S-transferase regulation, J. Biol. Chem, vol.277, pp.49220-49229, 2002.

P. Sta?ková, O. Ku?era, H. Lotková, T. Rou?ar, R. Endlicher et al., The toxic effect of thioacetamide on rat liver in vitro, Toxicol. In Vitro, vol.24, pp.2097-2103, 2010.

H. Hajovsky, G. Hu, Y. Koen, D. Sarma, W. Cui et al., Metabolism and toxicity of thioacetamide and thioacetamide S-oxide in rat hepatocytes, Chem. Res. Toxicol, vol.25, pp.1955-1963, 2012.

Y. Adjrah, S. D. Karou, A. Agbonon, K. Eklu-gadegbeku, C. De-souza et al., Toxicological assessment of effect of mancozeb-treated lettuce (Lactuca sativa) on wistar rat liver, Ethiop. J. Environ. Stud. Manag, vol.6, pp.67-73, 2013.

A. V. Pirozzi, A. Stellavato, A. La-gatta, M. Lamberti, and C. Schiraldi, Mancozeb, a fungicide routinely used in agriculture, worsens nonalcoholic fatty liver disease in the human HepG2 cell model, Toxicol. Lett, vol.249, pp.1-4, 2016.

A. Rogue, C. Lambert, C. Spire, N. Claude, and A. Guillouzo, Interindividual variability in gene expression profiles in human hepatocytes and comparison with HepaRG cells, Drug Metab. Dispos, vol.40, pp.151-158, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00865978

L. Peyta, K. Jarnouen, M. Pinault, C. Guimaraes, J. P. Pais-de-barros et al., Reduced cardiolipin content decreases respiratory chain capacities and increases ATP synthesis yield in the human HepaRG cells, Biochim. Biophys. Acta, vol.1857, pp.443-453, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01259219

K. P. Kanebratt and T. B. Andersson, Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies, Drug Metab. Dispos, vol.36, pp.1444-1452, 2008.

S. Anthérieu, C. Chesné, R. Li, C. Guguen-guillouzo, and A. Guillouzo, Optimization of the HepaRG cell model for drug metabolism and toxicity studies, Toxicol. In Vitro, vol.26, pp.1278-1285, 2012.

M. Demazeau, N. Quesnot, N. Ripoche, C. Rauch, J. Jefti? et al., Efficient transfection of Xenobiotic Responsive Element-biosensor plasmid using diether lipid and phosphatidylcholine liposomes in differentiated HepaRG cells, Int. J. Pharm, vol.524, pp.268-278, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01518045